ÂÜÀòÂÒÂ×

Ms. Motter serves as Interim Chief Financial Officer and Controller. She holds a master's in Business Administration from UCLA and is a licensed CPA and CGMA with more than 30 years of experience as an accounting professional. She worked as an Auditor with KPMG prior to entering the private sector. Her expertise in a variety of industries includes the establishment and management of all accounting, finance, treasury, budget, tax, credit, human resources, and administration functions in both start-up and existing operations.

Ms. Motter’s focus has been on life science startups and has been involved with companies in all stages of development, including founding, early-stage, pre-IPO, IPO, follow-on, and M&A activities. She works closely with CEOs to negotiate private investments and establish strategic plans for growth and development. She has also worked with her clients to manage non-dilutive financing including grant budgeting, accounting, and administration. She has been the CFO for many life science companies including Beta Cat, Kiromic, Salerius Pharmaceuticals, Vapogenix Inc., Nano3D Biosciences, CorInnova, LifeCell, Repros, Chrysalis, ProlX, Aronex, RGene Therapeutics, OrthoAccel, and Avisa.